🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase IV, randomised, placebo-controlled, double-blind, parallel ...
Status
Unknown
Location
Imperial College Healthcare NHS Trust
Start Date
2019-09-04
Trial ID
NCT03931161
Treatments Being Tested
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Tri...
Status
Completed
Location
Palatin Clinical Site 242
Start Date
2015-01
Trial ID
NCT02338960
Treatments Being Tested
Primary Objectives: * To demonstrate the superiority of alirocumab in comp...
Status
Completed
Location
Investigational Site Number 840020
Start Date
2015-10-23
Trial ID
NCT02585778
Treatments Being Tested
The purpose of this study is to evaluate the benefits and risks of lixisena...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-06
Trial ID
NCT00712673
Treatments Being Tested
Reduction of low-density lipoprotein cholesterol (LDL-C) levels effectively...
Status
Completed
Location
Basel University Hospital
Start Date
2018-01-23
Trial ID
NCT03287609
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-group tria...
Status
Recruiting
Location
Center for Neurolgoical Studies (CNS)
Start Date
2019-10-08
Trial ID
NCT04121780
Treatments Being Tested
The purpose of this study is to Evaluate the Efficacy and Safety of Subcuta...
Status
Completed
Location
Seoul National University Hospital
Start Date
2021-05-10
Trial ID
NCT04943068
Treatments Being Tested
To determine the efficacy, long-term safety, and tolerability of alirocumab...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT01926782
Treatments Being Tested
The purpose of this study is to evaluate the benefits and risks of lixisena...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-09
Trial ID
NCT00763451
Treatments Being Tested
110 individuals with stage 4-5 Chronic Kidney Disease (CKD) will be randomi...
Status
Withdrawn
Location
NYU Langone Nephrology Associates - Long Island
Start Date
2021-03-01
Trial ID
NCT04510844
Treatments Being Tested